Deneysel Sıçan Hidrosefali Modelinde Deksmedetomidinin Nöroenflamasyonun Üzerine Etkilerinin Radyolojik Olarak İncelenmesi
View/ Open
Date
2022-10-27Author
Yahya, Diaa K.A.
xmlui.dri2xhtml.METS-1.0.item-emb
Acik erisimxmlui.mirage2.itemSummaryView.MetaData
Show full item recordAbstract
ABSTRACT
Yahya D. Radiological investigation of the effects of dexmedetomidine
on hydrocephalus induced neuroinflamation in experimental rat hydrocephalus
model, Hacettepe University Faculty of Medicine, Department of
neurosurgery, Ankara 2022.
Introduction: As a result of ventriculomegaly and increased intracranial
pressure in hydrocephalus, there is a decrease in blood flow and ischemia,
especially in the periventricular white matter and subventricular zone.
Accordingly, a neuroinflammatory condition characterized by the proliferation
of astroglial and microglial cells occurs. This chain of events ultimately results
in functional loss due to loss of neurons, loss of myelin and decrease in
neurogenesis. This neuroinflammation can be seen radiologically in the form
of a decrease in cortical and corpus callosum thickness. In vitro studies have
shown that dexmedetomidine has anti-inflammatory and neuroprotective
effects in varying experimental models.
Purpose: In this study, it was aimed to radiologically investigate the
effects of dexmedetomidine on neuroinflamation in a hydrocephalus model
created by intracisternal kaolin injection.
Materials and Methods: In this study, a total of 21 male Sprague-
Dawley albino rats weighing between 330-385 g were used. The subjects were
divided into 3 separate groups (n=7). The subjects in the first group (Sham
group) were given 30μL SF into the cisterna magna. The second
(hydrocephalus group) and third ( treatment group) groups’ subjects were
injected intracisternally with 25% kaolin suspension dissolved in 30μL SF.
Brain MRI was performed on all subjects 14 days after the intracisternal
injeciton, and it was confirmed that hydrocephalus developed in the subjects
of the second and third groups. Then, for a week, subjects in the second group
were injected intraperitoneally with SF, and subjects in the third group were
injected intraperitoneally with 40 μg/kg/day of dexmedetomidine. On the 22nd
day of the experiment, a brain MRI was perfomed again on all subjects. Evans
index, ventricular area measurment, Corpus Callosum thickness, and cortical
thickness values were calculated from the images obtained. For statistical
analysis of the data GraphPad Prism 9 program was used.
Results: All parameters examined (Evans index, ventricular area
measurment, corpus callosum thickness, cortical thickness) were found to be
statistically significant compared to the sham group. However, there was no
significant difference between the hydrocephalus and treatment group.
Conclusion: As a result of the statistical analysis, a significant
difference was found between the sham group and the groups in which
hydrocephalus was fromed (hydrocephalus group and treatment group), which
indicates that an effective hydrocephalus has developed. However, there was
no significant difference between the hydrocephalus group and the treatment
group. In conclusion, there was no radiologically shown effect of
dexmedetomidine on the neuroinflammation occurring in hydrocephalus. To
confirm these results, we recommend to conduct histopathological studies.
Keywords: Hydrocephalus, Kaolin, Dexmedetomidine,
Neuroinflammation.